‹ All Posts
RAJIV GUPTA (SEBI RA)

23rd Aug 2025 · SEBI-Registered Analyst

Agreement with Foreign Government - Akums Drugs & Pharmaceuticals Ltd

Code BSE: 544222 NSE:

AKUMS
Akums Drugs and Pharmaceuticals Limited has executed a Framework Agreement on 22nd August, 2025 with Government of the Republic of Zambia to establish a local manufacturing facility in Zambia and to undertake the manufacturing and supply of Medicines in Zambia, with the objective of supporting GRZ national health programs and enhancing local production capabilities in Zambia. The facility, in the future, also plans to export to neighboring countries including, but not limited to, Zimbabwe, Namibia, Botswana, Malawi, Tanzania, Mozambique etc. This Project shall be implemented through incorporation of a new joint venture company in Zambia in which Akums will be a majority partner owning 51% stake and a nominated Zambian state instrumentality owning 49% stake. Scope being Manufacturing, marketing, distribution, and sale of pharmaceutical products and medical supplies in Republic of Zambia, including to undertake the manufacturing and supplying of Medicines in the other African countries.

#WatchOutFor#StockInNews
akums23082025.pdf
802 likes·33 comments